
David Gutstein MD
Nuclear Cardiology
Vice President, Strategic Program Direction, Hematology, Regeneron Pharmaceuticals; Adjunct Professor of Medicine, New York University Medical Center
Join to View Full Profile
777 Old Saw Mill River RdTarrytown, NY 10591
Dr. Gutstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 1995 - 1999
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1991 - 1994
- Northwestern University The Feinberg School of MedicineClass of 1991
Certifications & Licensure
- NY State Medical License 1995 - 2026
Awards, Honors, & Recognition
- Louis N. and Arnold M. Katz Basic Science Research Prize American Heart Association, 2000
Publications & Presentations
PubMed
- Operationalising a Haemophilia Gene Editing Lexicon for Practical Use.William McKeown, Cedric Hermans, Carmen Unzu, Mark A Kay, Flora Peyvandi
Haemophilia. 2025-03-01 - 1 citationsDevelopment of a novel gene editing lexicon for hemophilia: methodology and results.Craig M Kessler, Leonard A Valentino, Courtney D Thornburg, Carmen Unzu, Mark A Kay
Research and Practice in Thrombosis and Haemostasis. 2025-02-01 - 14 citationsCRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy.Marianna Fontana, Scott D Solomon, Jessica Kachadourian, Liron Walsh, Ricardo Rocha
The New England Journal of Medicine. 2024-12-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: